Prognostic factors for disease-free and overall survival of patients with uterine carcinosarcoma

ŞÜKÜR Y. E., TAŞKIN S., VARLI B., Ates C., GÜNGÖR M., Ortac F.

INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, cilt.23, sa.1, ss.114-120, 2018 (SCI-Expanded) identifier identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 23 Sayı: 1
  • Basım Tarihi: 2018
  • Doi Numarası: 10.1007/s10147-017-1181-3
  • Dergi Adı: INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.114-120
  • Anahtar Kelimeler: Lymphadenectomy, Lymph node metastasis, Residual tumor, Survival, Uterine carcinosarcoma, GYNECOLOGIC-ONCOLOGY-GROUP, STAGE-I, CYTOREDUCTIVE SURGERY, SARCOMA-GROUP, UTERUS, THERAPY, CANCER, LYMPHADENECTOMY, CARBOPLATIN, PACLITAXEL
  • Acıbadem Mehmet Ali Aydınlar Üniversitesi Adresli: Evet

Özet

Uterine carcinosarcoma (UCS) is a relatively rare and very aggressive tumor. The predictors of survival for patients with UCS have not been determined clearly yet. The aim of the present study was to investigate the possible predictors of disease-free survival (DFS) and overall survival (OS) for patients with UCS.